APO Research
Talk to an analyst

APO RESEARCH · REPORT

Metabotropic Glutamate Receptor 3

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Metabotropic Glutamate Receptor 3 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025187 pages

Choose your research edition.

Industry ResearchMetabotropic Glutamate Receptor 3 Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Metabotropic Glutamate Receptor 3 Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Metabotropic Glutamate Receptor 3 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Metabotropic Glutamate Receptor 3 Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Metabotropic Glutamate Receptor 3 Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Metabotropic Glutamate Receptor 3 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Metabotropic Glutamate Receptor 3 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Metabotropic Glutamate Receptor 3 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Metabotropic Glutamate Receptor 3 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Metabotropic Glutamate Receptor 3 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Metabotropic Glutamate Receptor 3 include Eli Lilly and Company, Prexton Therapeutics SA, Domain Therapeutics SA, Denovo Biopharma LLC, Aevi Genomic Medicine Inc and Addex Therapeutics Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Metabotropic Glutamate Receptor 3 market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Metabotropic Glutamate Receptor 3 and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Metabotropic Glutamate Receptor 3 revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Metabotropic Glutamate Receptor 3 market size, projected growth trends, production technologies, key applications, and end-use industries.

Metabotropic Glutamate Receptor 3 Segment by Company

Eli Lilly and Company

Prexton Therapeutics SA

Domain Therapeutics SA

Denovo Biopharma LLC

Aevi Genomic Medicine Inc

Addex Therapeutics Ltd

Metabotropic Glutamate Receptor 3 Segment by Type

DT-010991

LY-3020371

VU-0092273

Others

Metabotropic Glutamate Receptor 3 Segment by Application

Autism

Chronic Pain

Glioma

Others

Metabotropic Glutamate Receptor 3 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metabotropic Glutamate Receptor 3 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Metabotropic Glutamate Receptor 3 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metabotropic Glutamate Receptor 3.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Metabotropic Glutamate Receptor 3 in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Metabotropic Glutamate Receptor 3 industry.

Chapter 3: Detailed analysis of Metabotropic Glutamate Receptor 3 companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Metabotropic Glutamate Receptor 3revenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Metabotropic Glutamate Receptor 3 Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of DT-010991 Table 3. Key Players of LY-3020371 Table 4. Key Players of VU-0092273 Table 3. Key Players of Others Table 4. Global Metabotropic Glutamate Receptor 3 Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Autism Table 6. Key Players of Chronic Pain Table 7. Key Players of Glioma Table 8. Key Players of Others Table 9. Global Metabotropic Glutamate Receptor 3 Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Metabotropic Glutamate Receptor 3 Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Metabotropic Glutamate Receptor 3 Market Share by Region (2021-2026) Table 12. Global Metabotropic Glutamate Receptor 3 Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Metabotropic Glutamate Receptor 3 Market Share by Region (2027-2032) Table 14. Metabotropic Glutamate Receptor 3 Industry Trends Table 15. Metabotropic Glutamate Receptor 3 Industry Drivers Table 16. Metabotropic Glutamate Receptor 3 Industry Opportunities and Challenges Table 17. Metabotropic Glutamate Receptor 3 Industry Restraints Table 18. Global Metabotropic Glutamate Receptor 3 Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Metabotropic Glutamate Receptor 3 Revenue Market Share by Company (2021-2026) Table 20. Global Metabotropic Glutamate Receptor 3 Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Metabotropic Glutamate Receptor 3 Key Company Head Office and Area Served Table 22. Global Metabotropic Glutamate Receptor 3 Company, Product Type & Application Table 23. Global Metabotropic Glutamate Receptor 3 Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Metabotropic Glutamate Receptor 3 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Metabotropic Glutamate Receptor 3 Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Metabotropic Glutamate Receptor 3 Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Metabotropic Glutamate Receptor 3 Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Metabotropic Glutamate Receptor 3 Revenue Market Share by Type (2021-2026) Table 30. Global Metabotropic Glutamate Receptor 3 Revenue Market Share by Type (2027-2032) Table 31. Global Metabotropic Glutamate Receptor 3 Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Metabotropic Glutamate Receptor 3 Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Metabotropic Glutamate Receptor 3 Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Metabotropic Glutamate Receptor 3 Revenue Market Share by Application (2021-2026) Table 35. Global Metabotropic Glutamate Receptor 3 Revenue Market Share by Application (2027-2032) Table 36. Eli Lilly and Company Company Information Table 37. Eli Lilly and Company Business Overview Table 38. Eli Lilly and Company Metabotropic Glutamate Receptor 3 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Eli Lilly and Company Metabotropic Glutamate Receptor 3 Product Portfolio Table 40. Eli Lilly and Company Recent Development Table 41. Prexton Therapeutics SA Company Information Table 42. Prexton Therapeutics SA Business Overview Table 43. Prexton Therapeutics SA Metabotropic Glutamate Receptor 3 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Prexton Therapeutics SA Metabotropic Glutamate Receptor 3 Product Portfolio Table 45. Prexton Therapeutics SA Recent Development Table 46. Domain Therapeutics SA Company Information Table 47. Domain Therapeutics SA Business Overview Table 48. Domain Therapeutics SA Metabotropic Glutamate Receptor 3 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Domain Therapeutics SA Metabotropic Glutamate Receptor 3 Product Portfolio Table 50. Domain Therapeutics SA Recent Development Table 51. Denovo Biopharma LLC Company Information Table 52. Denovo Biopharma LLC Business Overview Table 53. Denovo Biopharma LLC Metabotropic Glutamate Receptor 3 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Denovo Biopharma LLC Metabotropic Glutamate Receptor 3 Product Portfolio Table 55. Denovo Biopharma LLC Recent Development Table 56. Aevi Genomic Medicine Inc Company Information Table 57. Aevi Genomic Medicine Inc Business Overview Table 58. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 3 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 3 Product Portfolio Table 60. Aevi Genomic Medicine Inc Recent Development Table 61. Addex Therapeutics Ltd Company Information Table 62. Addex Therapeutics Ltd Business Overview Table 63. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 3 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 3 Product Portfolio Table 65. Addex Therapeutics Ltd Recent Development Table 66. North America Metabotropic Glutamate Receptor 3 Market Size by Type (2021-2026) & (US$ Million) Table 67. North America Metabotropic Glutamate Receptor 3 Market Size by Type (2027-2032) & (US$ Million) Table 68. North America Metabotropic Glutamate Receptor 3 Market Size by Application (2021-2026) & (US$ Million) Table 69. North America Metabotropic Glutamate Receptor 3 Market Size by Application (2027-2032) & (US$ Million) Table 70. North America Metabotropic Glutamate Receptor 3 Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 71. North America Metabotropic Glutamate Receptor 3 Market Size by Country (2021-2026) Table 72. North America Metabotropic Glutamate Receptor 3 Market Size by Country (2027-2032) Table 73. Europe Metabotropic Glutamate Receptor 3 Market Size by Type (2021-2026) & (US$ Million) Table 74. Europe Metabotropic Glutamate Receptor 3 Market Size by Type (2027-2032) & (US$ Million) Table 75. Europe Metabotropic Glutamate Receptor 3 Market Size by Application (2021-2026) & (US$ Million) Table 76. Europe Metabotropic Glutamate Receptor 3 Market Size by Application (2027-2032) & (US$ Million) Table 77. Europe Metabotropic Glutamate Receptor 3 Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 78. Europe Metabotropic Glutamate Receptor 3 Market Size by Country (2021-2026) Table 79. Europe Metabotropic Glutamate Receptor 3 Market Size by Country (2027-2032) Table 80. China Metabotropic Glutamate Receptor 3 Market Size by Type (2021-2026) & (US$ Million) Table 81. China Metabotropic Glutamate Receptor 3 Market Size by Type (2027-2032) & (US$ Million) Table 82. China Metabotropic Glutamate Receptor 3 Market Size by Application (2021-2026) & (US$ Million) Table 83. China Metabotropic Glutamate Receptor 3 Market Size by Application (2027-2032) & (US$ Million) Table 84. Asia Metabotropic Glutamate Receptor 3 Market Size by Type (2021-2026) & (US$ Million) Table 85. Asia Metabotropic Glutamate Receptor 3 Market Size by Type (2027-2032) & (US$ Million) Table 86. Asia Metabotropic Glutamate Receptor 3 Market Size by Application (2021-2026) & (US$ Million) Table 87. Asia Metabotropic Glutamate Receptor 3 Market Size by Application (2027-2032) & (US$ Million) Table 88. Asia Metabotropic Glutamate Receptor 3 Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. Asia Metabotropic Glutamate Receptor 3 Market Size by Country (2021-2026) Table 90. Asia Metabotropic Glutamate Receptor 3 Market Size by Country (2027-2032) Table 91. South America, Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Type (2021-2026) & (US$ Million) Table 92. South America, Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Type (2027-2032) & (US$ Million) Table 93. South America, Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Application (2021-2026) & (US$ Million) Table 94. South America, Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Application (2027-2032) & (US$ Million) Table 95. South America, Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. South America, Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Country (2021-2026) Table 97. South America, Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Country (2027-2032) Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. Metabotropic Glutamate Receptor 3 Product Image Figure 2. Global Metabotropic Glutamate Receptor 3 Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Metabotropic Glutamate Receptor 3 Market Share by Type: 2025 VS 2032 Figure 4. DT-010991 Image Figure 5. LY-3020371 Image Figure 6. VU-0092273 Image Figure 7. Others Image Figure 8. Global Metabotropic Glutamate Receptor 3 Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Metabotropic Glutamate Receptor 3 Market Share by Application: 2025 VS 2032 Figure 10. Autism Image Figure 11. Chronic Pain Image Figure 12. Glioma Image Figure 13. Others Image Figure 14. Global Metabotropic Glutamate Receptor 3 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Metabotropic Glutamate Receptor 3 Market Size (2021-2032) & (US$ Million) Figure 16. Global Metabotropic Glutamate Receptor 3 Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Metabotropic Glutamate Receptor 3 Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Metabotropic Glutamate Receptor 3 Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Metabotropic Glutamate Receptor 3 Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Metabotropic Glutamate Receptor 3 Revenue Market Share by Type (2021-2032) Figure 23. Global Metabotropic Glutamate Receptor 3 Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Metabotropic Glutamate Receptor 3 Revenue Market Share by Application (2021-2032) Figure 25. North America Metabotropic Glutamate Receptor 3 Market Size (2021-2032) & (US$ Million) Figure 26. North America Metabotropic Glutamate Receptor 3 Market Share by Type (2021-2032) Figure 27. North America Metabotropic Glutamate Receptor 3 Market Share by Application (2021-2032) Figure 28. North America Metabotropic Glutamate Receptor 3 Market Share by Country (2021-2032) Figure 29. United States Metabotropic Glutamate Receptor 3 Market Size (2021-2032) & (US$ Million) Figure 30. Canada Metabotropic Glutamate Receptor 3 Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Metabotropic Glutamate Receptor 3 Market Size (2021-2032) & (US$ Million) Figure 32. Europe Metabotropic Glutamate Receptor 3 Market Size (2021-2032) & (US$ Million) Figure 33. Europe Metabotropic Glutamate Receptor 3 Market Share by Type (2021-2032) Figure 34. Europe Metabotropic Glutamate Receptor 3 Market Share by Application (2021-2032) Figure 35. Europe Metabotropic Glutamate Receptor 3 Market Share by Country (2021-2032) Figure 36. Germany Metabotropic Glutamate Receptor 3 Market Size (2021-2032) & (US$ Million) Figure 37. France Metabotropic Glutamate Receptor 3 Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Metabotropic Glutamate Receptor 3 Market Size (2021-2032) & (US$ Million) Figure 39. Italy Metabotropic Glutamate Receptor 3 Market Size (2021-2032) & (US$ Million) Figure 40. Russia Metabotropic Glutamate Receptor 3 Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Metabotropic Glutamate Receptor 3 Market Size (2021-2032) & (US$ Million) Figure 42. China Metabotropic Glutamate Receptor 3 Market Size (2021-2032) & (US$ Million) Figure 43. China Metabotropic Glutamate Receptor 3 Market Share by Type (2021-2032) Figure 44. China Metabotropic Glutamate Receptor 3 Market Share by Application (2021-2032) Figure 45. Asia Metabotropic Glutamate Receptor 3 Market Size (2021-2032) & (US$ Million) Figure 46. Asia Metabotropic Glutamate Receptor 3 Market Share by Type (2021-2032) Figure 47. Asia Metabotropic Glutamate Receptor 3 Market Share by Application (2021-2032) Figure 48. Asia Metabotropic Glutamate Receptor 3 Market Share by Country (2021-2032) Figure 49. Japan Metabotropic Glutamate Receptor 3 Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Metabotropic Glutamate Receptor 3 Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Metabotropic Glutamate Receptor 3 Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Metabotropic Glutamate Receptor 3 Market Size (2021-2032) & (US$ Million) Figure 53. India Metabotropic Glutamate Receptor 3 Market Size (2021-2032) & (US$ Million) Figure 54. Australia Metabotropic Glutamate Receptor 3 Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Metabotropic Glutamate Receptor 3 Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Metabotropic Glutamate Receptor 3 Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Metabotropic Glutamate Receptor 3 Market Share by Country (2021-2032) Figure 59. Brazil Metabotropic Glutamate Receptor 3 Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Metabotropic Glutamate Receptor 3 Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Metabotropic Glutamate Receptor 3 Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Metabotropic Glutamate Receptor 3 Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Metabotropic Glutamate Receptor 3 Market Size (2021-2032) & (US$ Million) Figure 64. UAE Metabotropic Glutamate Receptor 3 Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Metabotropic Glutamate Receptor 3 Market Size (2021-2032) & (US$ Million) Figure 66. Chile Metabotropic Glutamate Receptor 3 Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • DT-010991
  • LY-3020371
  • VU-0092273
  • Others
Applications
  • Autism
  • Chronic Pain
  • Glioma
  • Others
Companies covered
  • Eli Lilly and Company
  • Prexton Therapeutics SA
  • Domain Therapeutics SA
  • Denovo Biopharma LLC
  • Aevi Genomic Medicine Inc
  • Addex Therapeutics Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Metabotropic Glutamate Receptor 3 Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 DT-010991
  5. 1.2.3 LY-3020371
  6. 1.2.4 VU-0092273
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Metabotropic Glutamate Receptor 3 Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Autism
  11. 1.3.3 Chronic Pain
  12. 1.3.4 Glioma
  13. 1.3.5 Others
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Metabotropic Glutamate Receptor 3 Growth Trends by Region
  16. 1.5.1 Global Metabotropic Glutamate Receptor 3 Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Metabotropic Glutamate Receptor 3 Market Size by Region (2021-2026)
  18. 1.5.3 Metabotropic Glutamate Receptor 3 Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Metabotropic Glutamate Receptor 3 Market Dynamics
  1. 2.1 Metabotropic Glutamate Receptor 3 Industry Trends
  2. 2.2 Metabotropic Glutamate Receptor 3 Industry Drivers
  3. 2.3 Metabotropic Glutamate Receptor 3 Industry Opportunities and Challenges
  4. 2.4 Metabotropic Glutamate Receptor 3 Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Metabotropic Glutamate Receptor 3 Revenue by Company (2021-2026)
  2. 3.2 Global Metabotropic Glutamate Receptor 3 Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Metabotropic Glutamate Receptor 3 Key Company Head office and Area Served
  4. 3.4 Global Metabotropic Glutamate Receptor 3 Company, Product Type & Application
  5. 3.5 Global Metabotropic Glutamate Receptor 3 Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Metabotropic Glutamate Receptor 3 Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Metabotropic Glutamate Receptor 3 Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Metabotropic Glutamate Receptor 3 Tier 1, Tier 2, and Tier 3
4 Metabotropic Glutamate Receptor 3 Market by Type
  1. 4.1 Global Metabotropic Glutamate Receptor 3 Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Metabotropic Glutamate Receptor 3 Market Size by Type (2021-2032)
  3. 4.3 Global Metabotropic Glutamate Receptor 3 Market Size Share by Type (2021-2032)
5 Metabotropic Glutamate Receptor 3 Market by Application
  1. 5.1 Global Metabotropic Glutamate Receptor 3 Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Metabotropic Glutamate Receptor 3 Market Size by Application (2021-2032)
  3. 5.3 Global Metabotropic Glutamate Receptor 3 Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Eli Lilly and Company
  2. 6.1.1 Eli Lilly and Company Company Information
  3. 6.1.2 Eli Lilly and Company Business Overview
  4. 6.1.3 Eli Lilly and Company Metabotropic Glutamate Receptor 3 Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Eli Lilly and Company Metabotropic Glutamate Receptor 3 Product Portfolio
  6. 6.1.5 Eli Lilly and Company Recent Developments
  7. 6.2 Prexton Therapeutics SA
  8. 6.2.1 Prexton Therapeutics SA Company Information
  9. 6.2.2 Prexton Therapeutics SA Business Overview
  10. 6.2.3 Prexton Therapeutics SA Metabotropic Glutamate Receptor 3 Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Prexton Therapeutics SA Metabotropic Glutamate Receptor 3 Product Portfolio
  12. 6.2.5 Prexton Therapeutics SA Recent Developments
  13. 6.3 Domain Therapeutics SA
  14. 6.3.1 Domain Therapeutics SA Company Information
  15. 6.3.2 Domain Therapeutics SA Business Overview
  16. 6.3.3 Domain Therapeutics SA Metabotropic Glutamate Receptor 3 Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Domain Therapeutics SA Metabotropic Glutamate Receptor 3 Product Portfolio
  18. 6.3.5 Domain Therapeutics SA Recent Developments
  19. 6.4 Denovo Biopharma LLC
  20. 6.4.1 Denovo Biopharma LLC Company Information
  21. 6.4.2 Denovo Biopharma LLC Business Overview
  22. 6.4.3 Denovo Biopharma LLC Metabotropic Glutamate Receptor 3 Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Denovo Biopharma LLC Metabotropic Glutamate Receptor 3 Product Portfolio
  24. 6.4.5 Denovo Biopharma LLC Recent Developments
  25. 6.5 Aevi Genomic Medicine Inc
  26. 6.5.1 Aevi Genomic Medicine Inc Company Information
  27. 6.5.2 Aevi Genomic Medicine Inc Business Overview
  28. 6.5.3 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 3 Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 3 Product Portfolio
  30. 6.5.5 Aevi Genomic Medicine Inc Recent Developments
  31. 6.6 Addex Therapeutics Ltd
  32. 6.6.1 Addex Therapeutics Ltd Company Information
  33. 6.6.2 Addex Therapeutics Ltd Business Overview
  34. 6.6.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 3 Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 3 Product Portfolio
  36. 6.6.5 Addex Therapeutics Ltd Recent Developments
7 North America
  1. 7.1 North America Metabotropic Glutamate Receptor 3 Market Size (2021-2032)
  2. 7.2 North America Metabotropic Glutamate Receptor 3 Market Size by Type
  3. 7.2.1 North America Metabotropic Glutamate Receptor 3 Market Size by Type (2021-2026)
  4. 7.2.2 North America Metabotropic Glutamate Receptor 3 Market Size by Type (2027-2032)
  5. 7.2.3 North America Metabotropic Glutamate Receptor 3 Market Share by Type (2021-2032)
  6. 7.3 North America Metabotropic Glutamate Receptor 3 Market Size by Application
  7. 7.3.1 North America Metabotropic Glutamate Receptor 3 Market Size by Application (2021-2026)
  8. 7.3.2 North America Metabotropic Glutamate Receptor 3 Market Size by Application (2027-2032)
  9. 7.3.3 North America Metabotropic Glutamate Receptor 3 Market Share by Application (2021-2032)
  10. 7.4 North America Metabotropic Glutamate Receptor 3 Market Size by Country
  11. 7.4.1 North America Metabotropic Glutamate Receptor 3 Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Metabotropic Glutamate Receptor 3 Market Size by Country (2021-2026)
  13. 7.4.3 North America Metabotropic Glutamate Receptor 3 Market Size by Country (2027-2032)
  14. 7.4.4 North America Metabotropic Glutamate Receptor 3 Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Metabotropic Glutamate Receptor 3 Market Size (2021-2032)
  2. 8.2 Europe Metabotropic Glutamate Receptor 3 Market Size by Type
  3. 8.2.1 Europe Metabotropic Glutamate Receptor 3 Market Size by Type (2021-2026)
  4. 8.2.2 Europe Metabotropic Glutamate Receptor 3 Market Size by Type (2027-2032)
  5. 8.2.3 Europe Metabotropic Glutamate Receptor 3 Market Share by Type (2021-2032)
  6. 8.3 Europe Metabotropic Glutamate Receptor 3 Market Size by Application
  7. 8.3.1 Europe Metabotropic Glutamate Receptor 3 Market Size by Application (2021-2026)
  8. 8.3.2 Europe Metabotropic Glutamate Receptor 3 Market Size by Application (2027-2032)
  9. 8.3.3 Europe Metabotropic Glutamate Receptor 3 Market Share by Application (2021-2032)
  10. 8.4 Europe Metabotropic Glutamate Receptor 3 Market Size by Country
  11. 8.4.1 Europe Metabotropic Glutamate Receptor 3 Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Metabotropic Glutamate Receptor 3 Market Size by Country (2021-2026)
  13. 8.4.3 Europe Metabotropic Glutamate Receptor 3 Market Size by Country (2027-2032)
  14. 8.4.4 Europe Metabotropic Glutamate Receptor 3 Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Metabotropic Glutamate Receptor 3 Market Size (2021-2032)
  2. 9.2 China Metabotropic Glutamate Receptor 3 Market Size by Type
  3. 9.2.1 China Metabotropic Glutamate Receptor 3 Market Size by Type (2021-2026)
  4. 9.2.2 China Metabotropic Glutamate Receptor 3 Market Size by Type (2027-2032)
  5. 9.2.3 China Metabotropic Glutamate Receptor 3 Market Share by Type (2021-2032)
  6. 9.3 China Metabotropic Glutamate Receptor 3 Market Size by Application
  7. 9.3.1 China Metabotropic Glutamate Receptor 3 Market Size by Application (2021-2026)
  8. 9.3.2 China Metabotropic Glutamate Receptor 3 Market Size by Application (2027-2032)
  9. 9.3.3 China Metabotropic Glutamate Receptor 3 Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Metabotropic Glutamate Receptor 3 Market Size (2021-2032)
  2. 10.2 Asia Metabotropic Glutamate Receptor 3 Market Size by Type
  3. 10.2.1 Asia Metabotropic Glutamate Receptor 3 Market Size by Type (2021-2026)
  4. 10.2.2 Asia Metabotropic Glutamate Receptor 3 Market Size by Type (2027-2032)
  5. 10.2.3 Asia Metabotropic Glutamate Receptor 3 Market Share by Type (2021-2032)
  6. 10.3 Asia Metabotropic Glutamate Receptor 3 Market Size by Application
  7. 10.3.1 Asia Metabotropic Glutamate Receptor 3 Market Size by Application (2021-2026)
  8. 10.3.2 Asia Metabotropic Glutamate Receptor 3 Market Size by Application (2027-2032)
  9. 10.3.3 Asia Metabotropic Glutamate Receptor 3 Market Share by Application (2021-2032)
  10. 10.4 Asia Metabotropic Glutamate Receptor 3 Market Size by Country
  11. 10.4.1 Asia Metabotropic Glutamate Receptor 3 Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Metabotropic Glutamate Receptor 3 Market Size by Country (2021-2026)
  13. 10.4.3 Asia Metabotropic Glutamate Receptor 3 Market Size by Country (2027-2032)
  14. 10.4.4 Asia Metabotropic Glutamate Receptor 3 Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Metabotropic Glutamate Receptor 3 Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Metabotropic Glutamate Receptor 3 Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Metabotropic Glutamate Receptor 3 Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst